EUVIMEDEUVIMED entdecken
Open Access

Impact Of Medicaid Expansion On HIV Pre-Exposure Prophylaxis Coverage, 2012–23

Elizabeth M Stone, Nicholas J Seewald, Joseph G Rosen

Health Affairs · 2025

DOI: 10.1377/hlthaff.2025.00211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Affairs, 2025. Verfasst von Elizabeth M Stone und 2 weiteren Autor:innen. Beteiligte Einrichtung: Elizabeth M. Stone (elizabeth.stone@rutgers.edu), Rutgers University, New Brunswick, New Jersey. Hauptthemen laut MEDLINE: Medicaid, Pre-Exposure Prophylaxis, HIV Infections, Anti-HIV Agents. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although its availability has grown during the past decade, pre-exposure prophylaxis (PrEP) remains underused in the US. We evaluated the impact of Medicaid expansion on state-level PrEP prescribing outcomes, using HIV surveillance data from all fifty states and Washington, D.C., from the period 2012-23, using a staggered diffeence-in-differences approach. PrEP coverage (prescriptions per 100,000 population) increased over time but was not statistically significantly associated with Medicaid expansion. There were, however, significant increases in the PrEP-to-need ratio (4.44 PrEP prescriptions per new HIV diagnosis) that were attributable to Medicaid expansion, with the strength of effects increasing over time. Medicaid expansion was associated with significant increases in PrEP-to-need ratios across all subgroups. Although Medicaid expansion effectively increased PrEP access relative to HIV diagnoses, differential impacts by race and ethnicity may suggest widening racial and ethnic disparities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MedicaidPre-Exposure ProphylaxisHIV InfectionsAnti-HIV AgentsInsurance CoverageHumansUnited StatesMaleFemaleHealth Services AccessibilityAdultPatient Protection and Affordable Care Act

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Elizabeth M. Stone (elizabeth.stone@rutgers.edu), Rutgers University, New Brunswick, New Jersey.
  • Nicholas J. Seewald, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Joseph G. Rosen, Rhode Island Hospital, Providence, Rhode Island.

Förderung

  • NIGMS NIH HHS
  • NIAID NIH HHS
  • NIMH NIH HHS

Zitieren

APA

Stone, E. M., Seewald, N. J., & Rosen, J. G. (2025). Impact Of Medicaid Expansion On HIV Pre-Exposure Prophylaxis Coverage, 2012–23. Health Affairs. https://doi.org/10.1377/hlthaff.2025.00211

Vancouver

Stone EM, Seewald NJ, Rosen JG. Impact Of Medicaid Expansion On HIV Pre-Exposure Prophylaxis Coverage, 2012–23. Health Affairs. 2025. doi:10.1377/hlthaff.2025.00211

BibTeX
@article{Stone2025,
  author = {Stone, Elizabeth M and Seewald, Nicholas J and Rosen, Joseph G},
  title = {Impact Of Medicaid Expansion On HIV Pre-Exposure Prophylaxis Coverage, 2012–23},
  journal = {Health Affairs},
  year = {2025},
  doi = {10.1377/hlthaff.2025.00211}
}
Kostenlos starten →